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Editorial on the Research Topic
HLA and KIR Diversity and Polymorphisms: Emerging Concepts
Polymorphisms of immune system genes, including Human Leukocyte Antigens (HLA) and the
Killer Ig-Like Receptors (KIR), offer limitless depths of complexity. Jean Dausset, who shared the
Nobel Prize in 1980 for the discovery of the HLA system, when presented with new results showing
the role of specific amino acid polymorphisms on the function of HLA, responded enthusiastically
that “we need to go further and study HLA at the atomic level”.
The major histocompatibility complex (MHC) and KIR genetic loci are strongly associated
with the outcomes of infectious diseases, cancers, inflammatory and autoimmune diseases,
reproduction, and transplantation. Recent advances in characterizing HLA and KIR diversity in
human populations have led to translational impacts for bone marrow and solid organ
transplant matching.
There is currently robust discussion on the origins of HLA, MHC and KIR polymorphisms in
humans, primates and other mammals, but limited information about the effects of the
polymorphisms on interactions mediated by HLA and KIR. While both the HLA and KIR
immune genes regions have been independently associated with diseases and their outcomes, the
interactions between those regions has had limited attention. This Research Topic was conceived to
appeal to researchers that have found their way, via different paths, to the crossroads of the
polymorphisms and population dynamics of a particular immune sub-system with the recognition
that, to progress in our understanding, we also need to establish a form of systems immunology to
study the interaction of various polymorphic components.
There are established studies that focus on each of these areas: HLA, T cells, B cells, NK cells and
their receptors. We are interested in the intersection: what emerges in combination at the synapses
of specific molecules in the context of the entire organism or population.
The resulting Research Topic is 15 papers, 14 of which primarily focus on only one of the systems
in humans and primates, and provide important insights into receptor repertoire diversity,
diversification mechanisms, haplotypes, expression, sequencing, donor matching, peptide
repertoires, and disease linkages among:
-KIR and other NK receptors (Solloch et al.; Alicata et al.; Roe, Vierra-Green et al.; Roe, Williams
et al.; Roe and Kuang; Bruijnesteijn et al.; Cisneros et al.; Cubero et al.)org May 2021 | Volume 12 | Article 7013981
Maiers et al. Editorial: Immune Polymorphism-HLA/MHC (Yamamoto et al.; Kavadichanda et al.; Nunes
et al.; Kaufman)
-MICA/B (Klussmeier et al.)
-Immunoglobulin heavy chains (Rodriguez et al.)
Alas only one study explicitly focused on the interaction of
HLA and KIR (Vargas et al.).
The studies presented in these articles have implications for
understanding disease risk, outcomes and pathogenic
mechanisms, host defense outcomes, gene classification and
nomenclature, and transplantation. The studies also identify
a gap - the need for new ways to bring together researchers
in adjacent areas studying genetic polymorphism in
the different branches of the immune system and to expose
them to the various challenges, methods and advances in each
sub-field.
To that end, we have developed a charter for a new Society for
Immune Polymorphism - SIP. We envision this society as an
international membership organization of scientists dedicated to
understanding genetic and functional variations in the vertebrate
immune system, and the vertebrate immune system’s role in
health, disease, and evolutionary biology.
Our goal is to promote increased collaboration, engagement
and sharing of domain knowledge between scientists focused on
any aspects of immune-related genomics through the
following activities
• to provide a forum for basic science, and clinical, industrial,
and educational applicat ions related to immune
polymorphism.
• to share and disseminate research findings related to immune
polymorphism.
• to assist in the integration of immune polymorphism-related
data resources.Frontiers in Immunology | www.frontiersin.org 2• to promote the development of secure open-source, cloud-
based technologies that advance the analysis, collection,
exchange, and storage of immune-related genomic data.
The goals of SIP are not to replace any of the societies interesting
in a specific aspect of immune polymorphisms, but rather to allow
for fruitful collaborations between practitioners and researchers in
the different domains.We have organized twoworkshops in Ramat
Gan, Israel (Mar, 2018 https://louzouy.wixsite.com/hlakir2018/)
and in New Orleans (Oct, 2019 https://immunepolymorphism.
tulane.edu/). A plan for this type of article collection was conceived
at the first workshop.We plan to continue towork together in these
efforts and welcome broad participation from a diverse group of
researchers around the globe.
The society is still in its initial stages, further details about the
society, its goals, and possible collaborations between SIP and
other societies can be obtained from the corresponding authors
or the website: immunepolymorphismsociety.org.AUTHOR CONTRIBUTIONS
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